ATE107289T1 - Verfahren zur herstellung von 1-phenylimidazolin- 2,5-dion-derivate. - Google Patents

Verfahren zur herstellung von 1-phenylimidazolin- 2,5-dion-derivate.

Info

Publication number
ATE107289T1
ATE107289T1 AT90403725T AT90403725T ATE107289T1 AT E107289 T1 ATE107289 T1 AT E107289T1 AT 90403725 T AT90403725 T AT 90403725T AT 90403725 T AT90403725 T AT 90403725T AT E107289 T1 ATE107289 T1 AT E107289T1
Authority
AT
Austria
Prior art keywords
preparation
formula
image
phenylimidazoline
denote
Prior art date
Application number
AT90403725T
Other languages
English (en)
Inventor
Patrick Seuron
Daniel Varraillon
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of ATE107289T1 publication Critical patent/ATE107289T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Reinforced Plastic Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT90403725T 1989-12-22 1990-12-21 Verfahren zur herstellung von 1-phenylimidazolin- 2,5-dion-derivate. ATE107289T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8917046A FR2656302B1 (fr) 1989-12-22 1989-12-22 Nouveau procede de preparation de l'anandron et derives de l'anandron.

Publications (1)

Publication Number Publication Date
ATE107289T1 true ATE107289T1 (de) 1994-07-15

Family

ID=9388859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90403725T ATE107289T1 (de) 1989-12-22 1990-12-21 Verfahren zur herstellung von 1-phenylimidazolin- 2,5-dion-derivate.

Country Status (24)

Country Link
US (1) US5166358A (de)
EP (1) EP0436426B1 (de)
JP (1) JP2836041B2 (de)
KR (1) KR0173307B1 (de)
CN (1) CN1048011C (de)
AT (1) ATE107289T1 (de)
AU (1) AU628699B2 (de)
CA (1) CA2032988C (de)
CZ (1) CZ281655B6 (de)
DE (1) DE69009964T2 (de)
DK (1) DK0436426T3 (de)
ES (1) ES2055382T3 (de)
FI (1) FI103203B (de)
FR (1) FR2656302B1 (de)
HU (1) HU207301B (de)
IE (1) IE65510B1 (de)
IL (1) IL96696A (de)
NZ (1) NZ236621A (de)
PL (1) PL164694B1 (de)
PT (1) PT96313B (de)
RU (1) RU1836356C (de)
SK (1) SK278447B6 (de)
UA (1) UA27220C2 (de)
ZA (1) ZA909648B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5656651A (en) * 1995-06-16 1997-08-12 Biophysica Inc. Androgenic directed compositions
DE19540027A1 (de) * 1995-10-27 1997-04-30 Gruenenthal Gmbh Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
FR2741346B1 (fr) * 1995-11-16 1997-12-19 Roussel Uclaf Nouveau procede de preparation de derives phenylimidazolidine
FR2741342B1 (fr) * 1995-11-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
JPH1072446A (ja) * 1996-06-24 1998-03-17 Sumitomo Chem Co Ltd 1−置換−ヒダントイン類の製造法
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
MXPA02012605A (es) * 2000-06-28 2003-05-14 Squibb Bristol Myers Co Moduladores selectivos del receptor androgeno y metodo para su identificacion, dise°o y uso.
EP1854798A3 (de) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7087636B2 (en) 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
ATE502298T1 (de) * 2003-12-19 2011-04-15 Univ California Verfahren und materialien zur beurteilung von prostatakrebstherapien
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
SI2656842T1 (sl) 2006-03-27 2016-10-28 The Regents Of The University Of California Modulator androgenih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenimi receptorji
WO2007127010A2 (en) 2006-03-29 2007-11-08 The Regents Of The University Of California Diarylthiohydantoin compounds
EP2620432A3 (de) 2007-10-26 2013-12-18 The Regents Of the University of California Diarylhydantoinverbindungen
AU2011218173C1 (en) 2010-02-16 2015-04-16 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
NZ744456A (en) 2012-09-26 2019-09-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
PL2945628T3 (pl) 2013-01-15 2020-09-21 Aragon Pharmaceuticals, Inc. Modulator receptorów androgenowych w skojarzeniu z octanem abirateronu i prednizonem do leczenia nowotworu stercza
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
US10702508B2 (en) 2017-10-16 2020-07-07 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH166004A (de) * 1934-06-06 1933-12-15 Chem Fab Vormals Sandoz Verfahren zur Darstellung eines Derivates des 5,5-Phenyläthylhydantoins.
US2490813A (en) * 1944-11-29 1949-12-13 Standard Oil Co Continuous process for making aryl amines
US2759002A (en) * 1954-03-24 1956-08-14 Abbott Lab 3-benzyl hydantoin and process
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
US3914311A (en) * 1973-06-15 1975-10-21 Du Pont Preparation of aromatic secondary and tertiary amines using a nickel complex catalyst
DE2414613A1 (de) * 1974-03-26 1975-10-16 Bayer Ag 1-aryl-5-alkyliden-2,4-dioxo-imidazolidine
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
IL55774A (en) * 1977-10-28 1982-04-30 Sparamedica Ag Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture
GB1598166A (en) * 1978-05-23 1981-09-16 Lilly Industries Ltd 3,5-disubstituted hydantoin derivatives
US4764625A (en) * 1980-12-12 1988-08-16 Xerox Corporation Process for preparing arylamines
EP0091596B1 (de) * 1982-04-08 1991-09-11 Shell Internationale Researchmaatschappij B.V. Neue Hydantoine, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
IL96696A0 (en) 1991-09-16
JPH04103573A (ja) 1992-04-06
CZ656790A3 (en) 1996-08-14
AU628699B2 (en) 1992-09-17
CA2032988A1 (fr) 1991-06-23
PL288365A1 (en) 1991-09-09
KR0173307B1 (ko) 1999-02-01
PT96313A (pt) 1991-09-30
FR2656302B1 (fr) 1992-05-07
FI103203B1 (fi) 1999-05-14
RU1836356C (ru) 1993-08-23
HU207301B (en) 1993-03-29
HU908416D0 (en) 1991-07-29
CA2032988C (fr) 2003-04-29
EP0436426A1 (de) 1991-07-10
SK656790A3 (en) 1997-06-04
DE69009964D1 (de) 1994-07-21
FR2656302A1 (fr) 1991-06-28
DK0436426T3 (da) 1994-07-04
US5166358A (en) 1992-11-24
DE69009964T2 (de) 1994-10-13
PT96313B (pt) 1998-06-30
IE65510B1 (en) 1995-11-01
IL96696A (en) 1995-08-31
CZ281655B6 (cs) 1996-12-11
JP2836041B2 (ja) 1998-12-14
AU6826590A (en) 1991-06-27
IE904142A1 (en) 1991-07-03
UA27220C2 (uk) 2000-08-15
FI906366A0 (fi) 1990-12-21
CN1052666A (zh) 1991-07-03
CN1048011C (zh) 2000-01-05
EP0436426B1 (de) 1994-06-15
ES2055382T3 (es) 1994-08-16
FI906366L (fi) 1991-06-23
FI103203B (fi) 1999-05-14
KR910011799A (ko) 1991-08-07
SK278447B6 (en) 1997-06-04
ZA909648B (en) 1992-02-26
PL164694B1 (pl) 1994-09-30
NZ236621A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
ATE107289T1 (de) Verfahren zur herstellung von 1-phenylimidazolin- 2,5-dion-derivate.
DE69114637D1 (de) Verbesserte Verfahren zur Herstellung von Zyklopentadienyleisen(II)arenen.
BR8405160A (pt) Compostos sensiveis a luz,mistura sensivel a luz a base dos mesmos e processo para obtencao de tais compostos
DE69029334D1 (de) Verfahren zur Herstellung von Alkoxyiminoacetamid-Derivaten und ein Zwischenproduckt dafür
DE69226590D1 (de) Verfahren zur Herstellung von substituierten N-Aryl-1,2,4-Triazolopyrimidin-2-Sulfonamiden
PT71773A (de) Verfahren zur herstellung von substituierten oxirancarbonsauren
DE58907421D1 (de) Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE69513110D1 (de) Verfahren zur Herstellung von exotherm reagierenden Zusammensetzungen
ATE799T1 (de) Verfahren zur herstellung von isatosaeureanhydriden.
ATE88202T1 (de) Bismaleimid-siloxane und verfahren zu deren herstellung.
SE8001556L (sv) Tetrahydrobensotiazolylimidazolidinoner
ATE90682T1 (de) Verfahren zur herstellung von cefodizim.
ATE38665T1 (de) Verfahren zur herstellung von 5-perfluoralkyl-5,6-dihydrouracyl-derivaten und verwendbare zwischenprodukte.
ATE23993T1 (de) Verfahren zur herstellung von o,o'dithiobenzamiden.
DE69113323D1 (de) Verfahren zur Herstellung von alpha-Hydroxycarbonsäure amiden.
DE69011901D1 (de) 1-Arylsulfonyl-2-piperidinon-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen.
ATE42542T1 (de) 3-amino-azetidin, seine salze, verfahren zu deren herstellung und zwischenprodukte.
KR850000390A (ko) 치환된 알칸티오카복실산 유도체의 제조방법
DE59106854D1 (de) Verfahren zur Herstellung von N-(2-Chlor-pyridin-5-yl-methyl)-ethylendiamin.
DE69612337D1 (de) Verfahren zur Herstellung von Alkylanilin-Verbindungen
DE69700036D1 (de) Verfahren zur Substitution von Cyclopentadien
ATE11139T1 (de) 2-(n-aryl-n-1,2,3-thiadiazolylcarbonyl)aminobutyrolactone, verfahren zu ihrer herstellung, diese enthaltende fungizide mittel und ihre anwendung als fungizide.
ATE71618T1 (de) 2-anilino-chinoline, verfahren zu ihrer herstellung und diese enthaltende fungizide.
ATE17710T1 (de) Keten-0,0-acetale und verfahren zu ihrer herstellung.
ES483300A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time